Drug Information

Drug General Information
Drug ID
D0A2KW
Former ID
DNC007322
Drug Name
1-(bis(4-bromophenyl)methyl)-3-phenylurea
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527861]
Formula
C20H16Br2N2O
Canonical SMILES
C1=CC=C(C=C1)NC(=O)NC(C2=CC=C(C=C2)Br)C3=CC=C(C=C3)Br
InChI
1S/C20H16Br2N2O/c21-16-10-6-14(7-11-16)19(15-8-12-17(22)13-9-15)24-20(25)23-18-4-2-1-3-5-18/h1-13,19H,(H2,23,24,25)
InChIKey
MNUYZVNTMQHNEW-UHFFFAOYSA-N
PubChem Compound ID
44421550
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [527861]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 527861J Med Chem. 2005 Nov 17;48(23):7486-90.1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.
Ref 527861J Med Chem. 2005 Nov 17;48(23):7486-90.1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.